Page last updated: 2024-08-23

mefloquine and posaconazole

mefloquine has been researched along with posaconazole in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1
Fisher, E; García-Sastre, A; He, S; Kouznetsova, J; Long, Y; Martínez-Romero, C; Motabar, O; Qiu, X; Sanderson, PE; Shinn, P; Sun, W; Tawa, G; Williamson, PR; Xu, M; Yang, S; Zheng, W1

Reviews

3 review(s) available for mefloquine and posaconazole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent update on anti-dengue drug discovery.
    European journal of medicinal chemistry, 2019, Aug-15, Volume: 176

    Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication

2019
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022

Other Studies

1 other study(ies) available for mefloquine and posaconazole

ArticleYear
Synergistic drug combination effectively blocks Ebola virus infection.
    Antiviral research, 2017, Volume: 137

    Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Clarithromycin; Drug Combinations; Drug Synergism; Ebolavirus; Hemorrhagic Fever, Ebola; High-Throughput Screening Assays; Humans; Mefloquine; Sphingomyelin Phosphodiesterase; Toremifene; Triazoles; Vero Cells; Virus Internalization

2017